PUBLIC COMPANY
saveSamsung Bioepis Co Ltd
updated 15d ago
Samsung Biologics Co., Ltd. (Korean: 삼성바이오로직스) is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval128 co-mentions · 64 sources
- drugHADLIMA26 co-mentions · 13 sources
- drugPYZCHIVA26 co-mentions · 13 sources
- drugEPYSQLI20 co-mentions · 10 sources
- drugBYOOVIZ16 co-mentions · 8 sources
- drugustekinumab13 co-mentions · 13 sources
- drugadalimumab13 co-mentions · 13 sources
- drugHUMIRA13 co-mentions · 13 sources
pipeline
10
marketed
7
phase 3
0
catalysts ytd
4
approvals ytd
4
recalls ytd
0
Pipeline(10)
pipeline depth10 products
1Phase 17Marketed2Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that